CIK 0001636651 · Non-accelerated filer<br>Smaller reporting company
Ovid Therapeutics Inc.
Sign in to watch- Ticker
- OVID
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465270895
- Phone
- 212-776-4381
- Business address
- 441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 61 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-11 | Friedman Bart Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-11 | Bernstein Karen Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-02 | Rona Jeffrey A Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-05-17 | WILLIAMS DOUGLAS E Director | Grant or award · Stock Option (Right to Buy) | +1,750 | 1,750 | ||
| 2021-05-17 | Friedman Bart Director | Grant or award · Stock Option (Right to Buy) | +1,750 | 1,750 | ||
| 2021-05-17 | Duncan Barbara Gayle Director | Grant or award · Stock Option (Right to Buy) | +1,750 | 1,750 | ||
| 2021-05-17 | Bernstein Karen Director | Grant or award · Stock Option (Right to Buy) | +1,750 | 1,750 | ||
| 2021-02-05 | Tardio Jason Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-12-17 | Tardio Jason Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2020-12-17 | Perone Thomas Michael General Counsel, Secretary | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2020-12-17 | Rona Jeffrey A Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2020-12-17 | Rakhit Amit President and CMO | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2020-12-17 | LEVIN JEREMY M CEO | Grant or award · Stock Option (Right to Buy) | +650,000 | 650,000 | ||
| 2020-12-17 | Haasner Dirk SVP, Global Regulatory Affairs | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-12-17 | Daly Timothy EVP,Finance & Corp. Controller | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2020-11-25 | Perone Thomas Michael General Counsel, Secretary | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2020-11-25 | Tardio Jason Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2020-10-11 | Rona Jeffrey A Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-10-11 | Haasner Dirk SVP, Global Regulatory Affairs | Grant or award · Stock option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-10-11 | Perone Thomas Michael General Counsel, Secretary | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 6 of 7 · 123 trades